Publication: 4609

Publication: 4609

Alliance A221805: duloxetine to prevent oxaliplatin-induced chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled phase II study

DOI

Google Scholar

Citation:

Meeting Instance:: ASCO 2025
Year:: 2025
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: CCP
Primary Committee:: Symptom Inter
Sec. Committees:: GI Health Outcomes

Pharmas:
Grants:: 1UG1CA189823, ); U10CA180868 (NRG Oncology); U10CA180888 (SWOG); R01CA235726

Corr. Author:
Authors:: Ellen M. Lavoie Smith Minji Lee Mary R. Scott Heshan Liu Shauna Hillman Tracy Rieken Rachel Wills Julian Diaz-Cobo Maryam Lustberg Kathryn Ruddy Selina Chow Heidi D. Finnes Jeffrey Meyerhardt Eileen O'Reilly Tareq Al Baghdadi Narjust Florez Jordan Kharofa Rang Govindarajan David Zahrieh Charles Loprinzi

Networks:: LAPS-AL002, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NY016, MCRC, OH070

Study: Alliance-A221805
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: